drug

I-CAT

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
BEHAVIORAL
Pre-approval / investigational in the US
Developed by University of North Carolina, Chapel Hill
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
BEHAVIORAL

Indications

Trials

1
Targeting Stress Reactivity in Schizophrenia: Integrated Coping Awareness Therapy
NCT03067311—Completed

KOLs & investigators

3
Diana O. Perkins, MD, MPHKOL score 5
Piper S Meyer-Kalos, PhDKOL score 5
David L. Penn, PhDKOL score 5

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
University of North Carolina, Chapel Hill
company
trial
Targeting Stress Reactivity in Schizophrenia: Integrated Coping Awareness Therapy
NA
trial
indication
Schizophreniform Disorders
indication
Psychotic Disorders
indication
KOL
Diana O. Perkins, MD, MPH
KOL score 5
person
Piper S Meyer-Kalos, PhD
KOL score 5
person
David L. Penn, PhD
KOL score 5
person